1. Dive C, Evans CA, Whetton AD . Induction of apoptosis – new targets for cancer chemotherapy. Semin Cancer Biol 1992; 3: 417–427.
2. Hannun YA . Apoptosis and the dilemma of cancer chemotherapy. Blood 1997; 89: 1845–1853.
3. Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM . Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood 1997; 90: 3118–3129.
4. Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A et al. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 1997; 57: 62–67.
5. Kim CN, Wang X, Huang Y, Ibrado AM, Liu L, Fang G et al. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res 1997; 57: 3115–3120.